Global Isothermal Nucleic Acid Amplification Technology (INAAT) Production, Demand and Key Producers, 2022-2028
The isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. Isothermal amplification of nucleic acids is a simple process that rapidly and efficiently accumulates nucleic acid sequences at constant temperature.
This report studies the global Isothermal Nucleic Acid Amplification Technology (INAAT) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Isothermal Nucleic Acid Amplification Technology (INAAT), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Isothermal Nucleic Acid Amplification Technology (INAAT) that contribute to its increasing demand across many markets.
The global Isothermal Nucleic Acid Amplification Technology (INAAT) market size is expected to reach $ 11310 million by 2028, rising at a market growth of 8.3% CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Isothermal Nucleic Acid Amplification Technology (INAAT) total market, 2017-2028, (USD Million)
Global Isothermal Nucleic Acid Amplification Technology (INAAT) total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Isothermal Nucleic Acid Amplification Technology (INAAT) total market, key domestic companies and share, (USD Million)
Global Isothermal Nucleic Acid Amplification Technology (INAAT) revenue by player and market share 2017-2022, (USD Million)
Global Isothermal Nucleic Acid Amplification Technology (INAAT) total market by Type, CAGR, 2017-2028, (USD Million)
Global Isothermal Nucleic Acid Amplification Technology (INAAT) total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Isothermal Nucleic Acid Amplification Technology (INAAT) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, BioMerieux, Hologic, BD, Grifols, Quidel, Meridian Bioscience, Qiagen and Eiken Chemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Isothermal Nucleic Acid Amplification Technology (INAAT) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Region:
1. How big is the global Isothermal Nucleic Acid Amplification Technology (INAAT) market?
2. What is the demand of the global Isothermal Nucleic Acid Amplification Technology (INAAT) market?
3. What is the year over year growth of the global Isothermal Nucleic Acid Amplification Technology (INAAT) market?
4. What is the total value of the global Isothermal Nucleic Acid Amplification Technology (INAAT) market?
5. Who are the major players in the global Isothermal Nucleic Acid Amplification Technology (INAAT) market?
6. What are the growth factors driving the market demand?
This report studies the global Isothermal Nucleic Acid Amplification Technology (INAAT) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Isothermal Nucleic Acid Amplification Technology (INAAT), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Isothermal Nucleic Acid Amplification Technology (INAAT) that contribute to its increasing demand across many markets.
The global Isothermal Nucleic Acid Amplification Technology (INAAT) market size is expected to reach $ 11310 million by 2028, rising at a market growth of 8.3% CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Isothermal Nucleic Acid Amplification Technology (INAAT) total market, 2017-2028, (USD Million)
Global Isothermal Nucleic Acid Amplification Technology (INAAT) total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Isothermal Nucleic Acid Amplification Technology (INAAT) total market, key domestic companies and share, (USD Million)
Global Isothermal Nucleic Acid Amplification Technology (INAAT) revenue by player and market share 2017-2022, (USD Million)
Global Isothermal Nucleic Acid Amplification Technology (INAAT) total market by Type, CAGR, 2017-2028, (USD Million)
Global Isothermal Nucleic Acid Amplification Technology (INAAT) total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Isothermal Nucleic Acid Amplification Technology (INAAT) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, BioMerieux, Hologic, BD, Grifols, Quidel, Meridian Bioscience, Qiagen and Eiken Chemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Isothermal Nucleic Acid Amplification Technology (INAAT) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- LAMP
- TMA
- NEAR
- NASBA
- HDA
- SPIA
- Other
- Medical Diagnostic
- Scientific Research
- Food Testing
- Environmental Hygiene
- Other
- Abbott
- BioMerieux
- Hologic
- BD
- Grifols
- Quidel
- Meridian Bioscience
- Qiagen
- Eiken Chemical
- OptiGene
- HiberGene Diagnostic
- Lucigen
- Nippon Gene
- Mast Group
- New England Biolabs
- Ustar Biotechnologies
1. How big is the global Isothermal Nucleic Acid Amplification Technology (INAAT) market?
2. What is the demand of the global Isothermal Nucleic Acid Amplification Technology (INAAT) market?
3. What is the year over year growth of the global Isothermal Nucleic Acid Amplification Technology (INAAT) market?
4. What is the total value of the global Isothermal Nucleic Acid Amplification Technology (INAAT) market?
5. Who are the major players in the global Isothermal Nucleic Acid Amplification Technology (INAAT) market?
6. What are the growth factors driving the market demand?
'@LOT1 SUPPLY SUMMARY
1.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
1.2 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Isothermal Nucleic Acid Amplification Technology (INAAT) Total Market by Region
1.3.1 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2017-2028)
1.3.2 United States Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.3.3 China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.3.4 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.3.5 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.3.6 South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.3.7 ASEAN Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.3.8 India Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) COMPANIES COMPETITIVE ANALYSIS
2.1 World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Isothermal Nucleic Acid Amplification Technology (INAAT) in 2021
2.2.3 Global Concentration Ratios (CR8) for Isothermal Nucleic Acid Amplification Technology (INAAT) in 2021
2.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Company Evaluation Quadrant
2.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Overall Company Footprint Analysis
2.4.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Region Footprint
2.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Company Product Type Footprint
2.4.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Isothermal Nucleic Acid Amplification Technology (INAAT) Market Comparison
3.1.1 United States VS China: Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Isothermal Nucleic Acid Amplification Technology (INAAT) Major Players and Market Share, 2017-2022
3.2.1 Major Players of Isothermal Nucleic Acid Amplification Technology (INAAT) in United States, Headquarters (States, Country)
3.2.2 United States Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Domestic Player, (2017-2022)
3.3 China Isothermal Nucleic Acid Amplification Technology (INAAT) Major Players and Market Share, 2017-2022
3.3.1 Major Players of Isothermal Nucleic Acid Amplification Technology (INAAT) in China, Headquarters (Province, Country)
3.3.2 China Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Isothermal Nucleic Acid Amplification Technology (INAAT) Major Players and Market Share, 2017-2022
3.4.1 Major Players of Isothermal Nucleic Acid Amplification Technology (INAAT) in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 LAMP
4.2.2 TMA
4.2.3 NEAR
4.2.4 NASBA
4.2.5 HDA
4.2.6 SPIA
4.2.7 Other
4.3 Market Segment by Type
4.3.1 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2017-2022)
4.3.2 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2023-2028)
4.3.3 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Medical Diagnostic
5.2.2 Scientific Research
5.2.3 Food Testing
5.2.4 Environmental Hygiene
5.2.5 Environmental Hygiene
5.3 Market Segment by Application
5.3.1 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2017-2022)
5.3.2 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2023-2028)
5.3.3 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Abbott
6.1.1 Abbott Details
6.1.2 Abbott Major Business
6.1.3 Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.1.4 Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Abbott Recent Developments/Updates
6.1.6 Abbott Competitive Strengths & Weaknesses
6.2 BioMerieux
6.2.1 BioMerieux Details
6.2.2 BioMerieux Major Business
6.2.3 BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.2.4 BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 BioMerieux Recent Developments/Updates
6.2.6 BioMerieux Competitive Strengths & Weaknesses
6.3 Hologic
6.3.1 Hologic Details
6.3.2 Hologic Major Business
6.3.3 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.3.4 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Hologic Recent Developments/Updates
6.3.6 Hologic Competitive Strengths & Weaknesses
6.4 BD
6.4.1 BD Details
6.4.2 BD Major Business
6.4.3 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.4.4 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 BD Recent Developments/Updates
6.4.6 BD Competitive Strengths & Weaknesses
6.5 Grifols
6.5.1 Grifols Details
6.5.2 Grifols Major Business
6.5.3 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.5.4 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Grifols Recent Developments/Updates
6.5.6 Grifols Competitive Strengths & Weaknesses
6.6 Quidel
6.6.1 Quidel Details
6.6.2 Quidel Major Business
6.6.3 Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.6.4 Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Quidel Recent Developments/Updates
6.6.6 Quidel Competitive Strengths & Weaknesses
6.7 Meridian Bioscience
6.7.1 Meridian Bioscience Details
6.7.2 Meridian Bioscience Major Business
6.7.3 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.7.4 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Meridian Bioscience Recent Developments/Updates
6.7.6 Meridian Bioscience Competitive Strengths & Weaknesses
6.8 Qiagen
6.8.1 Qiagen Details
6.8.2 Qiagen Major Business
6.8.3 Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.8.4 Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Qiagen Recent Developments/Updates
6.8.6 Qiagen Competitive Strengths & Weaknesses
6.9 Eiken Chemical
6.9.1 Eiken Chemical Details
6.9.2 Eiken Chemical Major Business
6.9.3 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.9.4 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Eiken Chemical Recent Developments/Updates
6.9.6 Eiken Chemical Competitive Strengths & Weaknesses
6.10 OptiGene
6.10.1 OptiGene Details
6.10.2 OptiGene Major Business
6.10.3 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.10.4 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 OptiGene Recent Developments/Updates
6.10.6 OptiGene Competitive Strengths & Weaknesses
6.11 HiberGene Diagnostic
6.11.1 HiberGene Diagnostic Details
6.11.2 HiberGene Diagnostic Major Business
6.11.3 HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.11.4 HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 HiberGene Diagnostic Recent Developments/Updates
6.11.6 HiberGene Diagnostic Competitive Strengths & Weaknesses
6.12 Lucigen
6.12.1 Lucigen Details
6.12.2 Lucigen Major Business
6.12.3 Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.12.4 Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Lucigen Recent Developments/Updates
6.12.6 Lucigen Competitive Strengths & Weaknesses
6.13 Nippon Gene
6.13.1 Nippon Gene Details
6.13.2 Nippon Gene Major Business
6.13.3 Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.13.4 Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Nippon Gene Recent Developments/Updates
6.13.6 Nippon Gene Competitive Strengths & Weaknesses
6.14 Mast Group
6.14.1 Mast Group Details
6.14.2 Mast Group Major Business
6.14.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.14.4 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Mast Group Recent Developments/Updates
6.14.6 Mast Group Competitive Strengths & Weaknesses
6.15 New England Biolabs
6.15.1 New England Biolabs Details
6.15.2 New England Biolabs Major Business
6.15.3 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.15.4 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 New England Biolabs Recent Developments/Updates
6.15.6 New England Biolabs Competitive Strengths & Weaknesses
6.16 Ustar Biotechnologies
6.16.1 Ustar Biotechnologies Details
6.16.2 Ustar Biotechnologies Major Business
6.16.3 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.16.4 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Ustar Biotechnologies Recent Developments/Updates
6.16.6 Ustar Biotechnologies Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Isothermal Nucleic Acid Amplification Technology (INAAT) and Key Manufacturers
7.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Manufacturing Costs
7.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Production Process
7.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Isothermal Nucleic Acid Amplification Technology (INAAT) Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Typical Distributors
8.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
1.2 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Isothermal Nucleic Acid Amplification Technology (INAAT) Total Market by Region
1.3.1 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2017-2028)
1.3.2 United States Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.3.3 China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.3.4 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.3.5 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.3.6 South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.3.7 ASEAN Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.3.8 India Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) COMPANIES COMPETITIVE ANALYSIS
2.1 World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Isothermal Nucleic Acid Amplification Technology (INAAT) in 2021
2.2.3 Global Concentration Ratios (CR8) for Isothermal Nucleic Acid Amplification Technology (INAAT) in 2021
2.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Company Evaluation Quadrant
2.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Overall Company Footprint Analysis
2.4.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Region Footprint
2.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Company Product Type Footprint
2.4.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Isothermal Nucleic Acid Amplification Technology (INAAT) Market Comparison
3.1.1 United States VS China: Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Isothermal Nucleic Acid Amplification Technology (INAAT) Major Players and Market Share, 2017-2022
3.2.1 Major Players of Isothermal Nucleic Acid Amplification Technology (INAAT) in United States, Headquarters (States, Country)
3.2.2 United States Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Domestic Player, (2017-2022)
3.3 China Isothermal Nucleic Acid Amplification Technology (INAAT) Major Players and Market Share, 2017-2022
3.3.1 Major Players of Isothermal Nucleic Acid Amplification Technology (INAAT) in China, Headquarters (Province, Country)
3.3.2 China Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Isothermal Nucleic Acid Amplification Technology (INAAT) Major Players and Market Share, 2017-2022
3.4.1 Major Players of Isothermal Nucleic Acid Amplification Technology (INAAT) in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 LAMP
4.2.2 TMA
4.2.3 NEAR
4.2.4 NASBA
4.2.5 HDA
4.2.6 SPIA
4.2.7 Other
4.3 Market Segment by Type
4.3.1 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2017-2022)
4.3.2 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2023-2028)
4.3.3 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Medical Diagnostic
5.2.2 Scientific Research
5.2.3 Food Testing
5.2.4 Environmental Hygiene
5.2.5 Environmental Hygiene
5.3 Market Segment by Application
5.3.1 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2017-2022)
5.3.2 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2023-2028)
5.3.3 World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Abbott
6.1.1 Abbott Details
6.1.2 Abbott Major Business
6.1.3 Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.1.4 Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Abbott Recent Developments/Updates
6.1.6 Abbott Competitive Strengths & Weaknesses
6.2 BioMerieux
6.2.1 BioMerieux Details
6.2.2 BioMerieux Major Business
6.2.3 BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.2.4 BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 BioMerieux Recent Developments/Updates
6.2.6 BioMerieux Competitive Strengths & Weaknesses
6.3 Hologic
6.3.1 Hologic Details
6.3.2 Hologic Major Business
6.3.3 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.3.4 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Hologic Recent Developments/Updates
6.3.6 Hologic Competitive Strengths & Weaknesses
6.4 BD
6.4.1 BD Details
6.4.2 BD Major Business
6.4.3 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.4.4 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 BD Recent Developments/Updates
6.4.6 BD Competitive Strengths & Weaknesses
6.5 Grifols
6.5.1 Grifols Details
6.5.2 Grifols Major Business
6.5.3 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.5.4 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Grifols Recent Developments/Updates
6.5.6 Grifols Competitive Strengths & Weaknesses
6.6 Quidel
6.6.1 Quidel Details
6.6.2 Quidel Major Business
6.6.3 Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.6.4 Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Quidel Recent Developments/Updates
6.6.6 Quidel Competitive Strengths & Weaknesses
6.7 Meridian Bioscience
6.7.1 Meridian Bioscience Details
6.7.2 Meridian Bioscience Major Business
6.7.3 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.7.4 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Meridian Bioscience Recent Developments/Updates
6.7.6 Meridian Bioscience Competitive Strengths & Weaknesses
6.8 Qiagen
6.8.1 Qiagen Details
6.8.2 Qiagen Major Business
6.8.3 Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.8.4 Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Qiagen Recent Developments/Updates
6.8.6 Qiagen Competitive Strengths & Weaknesses
6.9 Eiken Chemical
6.9.1 Eiken Chemical Details
6.9.2 Eiken Chemical Major Business
6.9.3 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.9.4 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Eiken Chemical Recent Developments/Updates
6.9.6 Eiken Chemical Competitive Strengths & Weaknesses
6.10 OptiGene
6.10.1 OptiGene Details
6.10.2 OptiGene Major Business
6.10.3 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.10.4 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 OptiGene Recent Developments/Updates
6.10.6 OptiGene Competitive Strengths & Weaknesses
6.11 HiberGene Diagnostic
6.11.1 HiberGene Diagnostic Details
6.11.2 HiberGene Diagnostic Major Business
6.11.3 HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.11.4 HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 HiberGene Diagnostic Recent Developments/Updates
6.11.6 HiberGene Diagnostic Competitive Strengths & Weaknesses
6.12 Lucigen
6.12.1 Lucigen Details
6.12.2 Lucigen Major Business
6.12.3 Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.12.4 Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Lucigen Recent Developments/Updates
6.12.6 Lucigen Competitive Strengths & Weaknesses
6.13 Nippon Gene
6.13.1 Nippon Gene Details
6.13.2 Nippon Gene Major Business
6.13.3 Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.13.4 Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Nippon Gene Recent Developments/Updates
6.13.6 Nippon Gene Competitive Strengths & Weaknesses
6.14 Mast Group
6.14.1 Mast Group Details
6.14.2 Mast Group Major Business
6.14.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.14.4 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Mast Group Recent Developments/Updates
6.14.6 Mast Group Competitive Strengths & Weaknesses
6.15 New England Biolabs
6.15.1 New England Biolabs Details
6.15.2 New England Biolabs Major Business
6.15.3 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.15.4 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 New England Biolabs Recent Developments/Updates
6.15.6 New England Biolabs Competitive Strengths & Weaknesses
6.16 Ustar Biotechnologies
6.16.1 Ustar Biotechnologies Details
6.16.2 Ustar Biotechnologies Major Business
6.16.3 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
6.16.4 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Ustar Biotechnologies Recent Developments/Updates
6.16.6 Ustar Biotechnologies Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Isothermal Nucleic Acid Amplification Technology (INAAT) and Key Manufacturers
7.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Manufacturing Costs
7.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Production Process
7.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Isothermal Nucleic Acid Amplification Technology (INAAT) Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Typical Distributors
8.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2017-2022) & (USD Million)
Table 3. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2023-2028) & (USD Million)
Table 4. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Region (2017-2022)
Table 5. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Isothermal Nucleic Acid Amplification Technology (INAAT) Players in 2021
Table 9. World Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Company Evaluation Quadrant
Table 11. Head Office of Key Isothermal Nucleic Acid Amplification Technology (INAAT) Player
Table 12. Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Company Product Type Footprint
Table 13. Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Company Product Application Footprint
Table 14. Isothermal Nucleic Acid Amplification Technology (INAAT) Mergers & Acquisitions Activity
Table 15. United States VS China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Isothermal Nucleic Acid Amplification Technology (INAAT) in United States, Headquarters (States, Country)
Table 17. United States Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Isothermal Nucleic Acid Amplification Technology (INAAT) in China, Company Headquarters (Province, Country)
Table 20. China Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Isothermal Nucleic Acid Amplification Technology (INAAT) in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Type (2017-2022) & (USD Million)
Table 27. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Type (2023-2028) & (USD Million)
Table 28. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Application (2017-2022) & (USD Million)
Table 30. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Application (2023-2028) & (USD Million)
Table 31. Abbott Basic Information, Area Served and Competitors
Table 32. Abbott Major Business
Table 33. Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 34. Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Abbott Recent Developments/Updates
Table 36. Abbott Competitive Strengths & Weaknesses
Table 37. BioMerieux Basic Information, Area Served and Competitors
Table 38. BioMerieux Major Business
Table 39. BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 40. BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. BioMerieux Recent Developments/Updates
Table 42. BioMerieux Competitive Strengths & Weaknesses
Table 43. Hologic Basic Information, Area Served and Competitors
Table 44. Hologic Major Business
Table 45. Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 46. Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Hologic Recent Developments/Updates
Table 48. Hologic Competitive Strengths & Weaknesses
Table 49. BD Basic Information, Area Served and Competitors
Table 50. BD Major Business
Table 51. BD Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 52. BD Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. BD Recent Developments/Updates
Table 54. BD Competitive Strengths & Weaknesses
Table 55. Grifols Basic Information, Area Served and Competitors
Table 56. Grifols Major Business
Table 57. Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 58. Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Grifols Recent Developments/Updates
Table 60. Grifols Competitive Strengths & Weaknesses
Table 61. Quidel Basic Information, Area Served and Competitors
Table 62. Quidel Major Business
Table 63. Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 64. Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Quidel Recent Developments/Updates
Table 66. Quidel Competitive Strengths & Weaknesses
Table 67. Meridian Bioscience Basic Information, Area Served and Competitors
Table 68. Meridian Bioscience Major Business
Table 69. Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 70. Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Meridian Bioscience Recent Developments/Updates
Table 72. Meridian Bioscience Competitive Strengths & Weaknesses
Table 73. Qiagen Basic Information, Area Served and Competitors
Table 74. Qiagen Major Business
Table 75. Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 76. Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Qiagen Recent Developments/Updates
Table 78. Qiagen Competitive Strengths & Weaknesses
Table 79. Eiken Chemical Basic Information, Area Served and Competitors
Table 80. Eiken Chemical Major Business
Table 81. Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 82. Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Eiken Chemical Recent Developments/Updates
Table 84. Eiken Chemical Competitive Strengths & Weaknesses
Table 85. OptiGene Basic Information, Area Served and Competitors
Table 86. OptiGene Major Business
Table 87. OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 88. OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. OptiGene Recent Developments/Updates
Table 90. OptiGene Competitive Strengths & Weaknesses
Table 91. HiberGene Diagnostic Basic Information, Area Served and Competitors
Table 92. HiberGene Diagnostic Major Business
Table 93. HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 94. HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. HiberGene Diagnostic Recent Developments/Updates
Table 96. HiberGene Diagnostic Competitive Strengths & Weaknesses
Table 97. Lucigen Basic Information, Area Served and Competitors
Table 98. Lucigen Major Business
Table 99. Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 100. Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Lucigen Recent Developments/Updates
Table 102. Lucigen Competitive Strengths & Weaknesses
Table 103. Nippon Gene Basic Information, Area Served and Competitors
Table 104. Nippon Gene Major Business
Table 105. Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 106. Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Nippon Gene Recent Developments/Updates
Table 108. Nippon Gene Competitive Strengths & Weaknesses
Table 109. Mast Group Basic Information, Area Served and Competitors
Table 110. Mast Group Major Business
Table 111. Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 112. Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Mast Group Recent Developments/Updates
Table 114. Mast Group Competitive Strengths & Weaknesses
Table 115. New England Biolabs Basic Information, Area Served and Competitors
Table 116. New England Biolabs Major Business
Table 117. New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 118. New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. New England Biolabs Recent Developments/Updates
Table 120. Ustar Biotechnologies Basic Information, Area Served and Competitors
Table 121. Ustar Biotechnologies Major Business
Table 122. Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 123. Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 124. Isothermal Nucleic Acid Amplification Technology (INAAT) Raw Material
Table 125. Key Manufacturers of Isothermal Nucleic Acid Amplification Technology (INAAT) Raw Materials
Table 126. Isothermal Nucleic Acid Amplification Technology (INAAT) Typical Distributors
Table 127. Isothermal Nucleic Acid Amplification Technology (INAAT) Typical Customers
Table 1. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2017-2022) & (USD Million)
Table 3. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2023-2028) & (USD Million)
Table 4. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Region (2017-2022)
Table 5. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Isothermal Nucleic Acid Amplification Technology (INAAT) Players in 2021
Table 9. World Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Company Evaluation Quadrant
Table 11. Head Office of Key Isothermal Nucleic Acid Amplification Technology (INAAT) Player
Table 12. Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Company Product Type Footprint
Table 13. Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Company Product Application Footprint
Table 14. Isothermal Nucleic Acid Amplification Technology (INAAT) Mergers & Acquisitions Activity
Table 15. United States VS China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Isothermal Nucleic Acid Amplification Technology (INAAT) in United States, Headquarters (States, Country)
Table 17. United States Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Isothermal Nucleic Acid Amplification Technology (INAAT) in China, Company Headquarters (Province, Country)
Table 20. China Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Isothermal Nucleic Acid Amplification Technology (INAAT) in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Type (2017-2022) & (USD Million)
Table 27. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Type (2023-2028) & (USD Million)
Table 28. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Application (2017-2022) & (USD Million)
Table 30. World Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Application (2023-2028) & (USD Million)
Table 31. Abbott Basic Information, Area Served and Competitors
Table 32. Abbott Major Business
Table 33. Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 34. Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Abbott Recent Developments/Updates
Table 36. Abbott Competitive Strengths & Weaknesses
Table 37. BioMerieux Basic Information, Area Served and Competitors
Table 38. BioMerieux Major Business
Table 39. BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 40. BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. BioMerieux Recent Developments/Updates
Table 42. BioMerieux Competitive Strengths & Weaknesses
Table 43. Hologic Basic Information, Area Served and Competitors
Table 44. Hologic Major Business
Table 45. Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 46. Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Hologic Recent Developments/Updates
Table 48. Hologic Competitive Strengths & Weaknesses
Table 49. BD Basic Information, Area Served and Competitors
Table 50. BD Major Business
Table 51. BD Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 52. BD Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. BD Recent Developments/Updates
Table 54. BD Competitive Strengths & Weaknesses
Table 55. Grifols Basic Information, Area Served and Competitors
Table 56. Grifols Major Business
Table 57. Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 58. Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Grifols Recent Developments/Updates
Table 60. Grifols Competitive Strengths & Weaknesses
Table 61. Quidel Basic Information, Area Served and Competitors
Table 62. Quidel Major Business
Table 63. Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 64. Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Quidel Recent Developments/Updates
Table 66. Quidel Competitive Strengths & Weaknesses
Table 67. Meridian Bioscience Basic Information, Area Served and Competitors
Table 68. Meridian Bioscience Major Business
Table 69. Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 70. Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Meridian Bioscience Recent Developments/Updates
Table 72. Meridian Bioscience Competitive Strengths & Weaknesses
Table 73. Qiagen Basic Information, Area Served and Competitors
Table 74. Qiagen Major Business
Table 75. Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 76. Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Qiagen Recent Developments/Updates
Table 78. Qiagen Competitive Strengths & Weaknesses
Table 79. Eiken Chemical Basic Information, Area Served and Competitors
Table 80. Eiken Chemical Major Business
Table 81. Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 82. Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Eiken Chemical Recent Developments/Updates
Table 84. Eiken Chemical Competitive Strengths & Weaknesses
Table 85. OptiGene Basic Information, Area Served and Competitors
Table 86. OptiGene Major Business
Table 87. OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 88. OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. OptiGene Recent Developments/Updates
Table 90. OptiGene Competitive Strengths & Weaknesses
Table 91. HiberGene Diagnostic Basic Information, Area Served and Competitors
Table 92. HiberGene Diagnostic Major Business
Table 93. HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 94. HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. HiberGene Diagnostic Recent Developments/Updates
Table 96. HiberGene Diagnostic Competitive Strengths & Weaknesses
Table 97. Lucigen Basic Information, Area Served and Competitors
Table 98. Lucigen Major Business
Table 99. Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 100. Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Lucigen Recent Developments/Updates
Table 102. Lucigen Competitive Strengths & Weaknesses
Table 103. Nippon Gene Basic Information, Area Served and Competitors
Table 104. Nippon Gene Major Business
Table 105. Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 106. Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Nippon Gene Recent Developments/Updates
Table 108. Nippon Gene Competitive Strengths & Weaknesses
Table 109. Mast Group Basic Information, Area Served and Competitors
Table 110. Mast Group Major Business
Table 111. Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 112. Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Mast Group Recent Developments/Updates
Table 114. Mast Group Competitive Strengths & Weaknesses
Table 115. New England Biolabs Basic Information, Area Served and Competitors
Table 116. New England Biolabs Major Business
Table 117. New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 118. New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. New England Biolabs Recent Developments/Updates
Table 120. Ustar Biotechnologies Basic Information, Area Served and Competitors
Table 121. Ustar Biotechnologies Major Business
Table 122. Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Services
Table 123. Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 124. Isothermal Nucleic Acid Amplification Technology (INAAT) Raw Material
Table 125. Key Manufacturers of Isothermal Nucleic Acid Amplification Technology (INAAT) Raw Materials
Table 126. Isothermal Nucleic Acid Amplification Technology (INAAT) Typical Distributors
Table 127. Isothermal Nucleic Acid Amplification Technology (INAAT) Typical Customers
LIST OF FIGURES
Figure 1. Isothermal Nucleic Acid Amplification Technology (INAAT) Picture
Figure 2. World Isothermal Nucleic Acid Amplification Technology (INAAT) Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Isothermal Nucleic Acid Amplification Technology (INAAT) Total Market Size (2017-2028) & (USD Million)
Figure 4. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Region (2017-2028)
Figure 5. United States Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 6. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 7. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 8. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 11. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 12. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Isothermal Nucleic Acid Amplification Technology (INAAT) by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Isothermal Nucleic Acid Amplification Technology (INAAT) Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Isothermal Nucleic Acid Amplification Technology (INAAT) Markets in 2021
Figure 17. United States VS China: Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Type in 2021
Figure 20. LAMP
Figure 21. TMA
Figure 22. NEAR
Figure 23. NASBA
Figure 24. HDA
Figure 25. SPIA
Figure 26. Other
Figure 27. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Type (2017-2028)
Figure 28. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 29. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Application in 2021
Figure 30. Medical Diagnostic
Figure 31. Scientific Research
Figure 32. Food Testing
Figure 33. Environmental Hygiene
Figure 34. Other
Figure 35. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Application (2017-2028)
Figure 36. Manufacturing Cost Structure Analysis of Isothermal Nucleic Acid Amplification Technology (INAAT) in 2021
Figure 37. Manufacturing Process Analysis of Isothermal Nucleic Acid Amplification Technology (INAAT)
Figure 38. Isothermal Nucleic Acid Amplification Technology (INAAT) Industrial Chain
Figure 39. Distribution Channel Breakdown for Isothermal Nucleic Acid Amplification Technology (INAAT) Shipments (%): 2017-2028
Figure 40. Direct Channel Pros & Cons
Figure 41. Indirect Channel Pros & Cons
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. Isothermal Nucleic Acid Amplification Technology (INAAT) Picture
Figure 2. World Isothermal Nucleic Acid Amplification Technology (INAAT) Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Isothermal Nucleic Acid Amplification Technology (INAAT) Total Market Size (2017-2028) & (USD Million)
Figure 4. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Region (2017-2028)
Figure 5. United States Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 6. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 7. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 8. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 11. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2017-2028) & (USD Million)
Figure 12. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Isothermal Nucleic Acid Amplification Technology (INAAT) by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Isothermal Nucleic Acid Amplification Technology (INAAT) Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Isothermal Nucleic Acid Amplification Technology (INAAT) Markets in 2021
Figure 17. United States VS China: Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Type in 2021
Figure 20. LAMP
Figure 21. TMA
Figure 22. NEAR
Figure 23. NASBA
Figure 24. HDA
Figure 25. SPIA
Figure 26. Other
Figure 27. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Type (2017-2028)
Figure 28. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 29. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Application in 2021
Figure 30. Medical Diagnostic
Figure 31. Scientific Research
Figure 32. Food Testing
Figure 33. Environmental Hygiene
Figure 34. Other
Figure 35. World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Application (2017-2028)
Figure 36. Manufacturing Cost Structure Analysis of Isothermal Nucleic Acid Amplification Technology (INAAT) in 2021
Figure 37. Manufacturing Process Analysis of Isothermal Nucleic Acid Amplification Technology (INAAT)
Figure 38. Isothermal Nucleic Acid Amplification Technology (INAAT) Industrial Chain
Figure 39. Distribution Channel Breakdown for Isothermal Nucleic Acid Amplification Technology (INAAT) Shipments (%): 2017-2028
Figure 40. Direct Channel Pros & Cons
Figure 41. Indirect Channel Pros & Cons
Figure 42. Methodology
Figure 43. Research Process and Data Source
